n-(3-(aminomethyl)benzyl)acetamidine has been researched along with transforming growth factor beta in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chambers, TJ; Fox, SW | 1 |
| Capelozzi, VL; Leick-Maldonado, EA; Martins, Mde A; Prado, CM; Rocha, G; Starling, CM; Tibério, IF; Yano, L | 1 |
| Ager, EI; Askoxylakis, V; Boucher, Y; Devy, L; Dransfield, DT; Finkelstein, DM; Fukumura, D; Goel, S; Huang, Y; Jain, RK; Kirkpatrick, ND; Kodack, DP; Kozin, SV; Muzikansky, A; Seano, G; Snuderl, M | 1 |
3 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and transforming growth factor beta
| Article | Year |
|---|---|
Interferon-gamma directly inhibits TRANCE-induced osteoclastogenesis.
Topics: Amidines; Animals; Benzylamines; Biomarkers; Bone and Bones; Bone Resorption; Carrier Proteins; Cattle; Cell Count; Cell Differentiation; Cell Lineage; Cells, Cultured; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; In Vitro Techniques; Interferon-gamma; Macrophage Colony-Stimulating Factor; Male; Membrane Glycoproteins; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Osteoclasts; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2000 |
Effects of inducible nitric oxide synthase inhibition in bronchial vascular remodeling-induced by chronic allergic pulmonary inflammation.
Topics: Administration, Inhalation; Amidines; Animals; Asthma; Benzylamines; Blood Vessels; Bronchi; Collagen; Elastic Tissue; Enzyme Inhibitors; Extracellular Matrix; Guinea Pigs; Male; Matrix Metalloproteinase 9; Nitric Oxide; Nitric Oxide Synthase Type II; Ovalbumin; Pneumonia; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta | 2011 |
Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.
Topics: Amidines; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Dose Fractionation, Radiation; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunoglobulin G; Macrophages; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 14; Mice; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Phenotype; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Up-Regulation | 2015 |